Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Modelling the cost effectiveness of lamivudine/zidovudine combination therapy in HIV infection.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Modelling the cost effectiveness of lamivudine/zidovudine combination therapy in HIV infection.
Modelling the cost effectiveness of lamivudine/zidovudine combination therapy in HIV infection. Pharmacoeconomics. 1997 Jul; 12(1):54-66.
View in:
PubMed
subject areas
Adult
Cost-Benefit Analysis
Drug Combinations
Female
HIV Infections
HIV-1
Humans
Lamivudine
Male
Models, Economic
Zidovudine
authors with profiles
Kit N. Simpson